Elequin Capital’s Exact Sciences EXAS Stock Holding History

Elequin Capital’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-539	Closed	-$54.7K	–	653
2025 Q4	$54.7K	Buy	+539	New	+$43.3K	﹤0.01%	139
2025 Q1	–	Sell	-412	Closed	-$23.1K	–	421
2024 Q4	$23.1K	Sell	412 -256	-38%	-$15.9K	﹤0.01%	239
2024 Q3	$45.5K	Buy	+668	New	+$37.7K	0.01%	55
2024 Q2	–	Sell	-452	Closed	-$31.2K	–	237
2024 Q1	$31.2K	Buy	+452	New	+$28.6K	0.01%	37
2023 Q3	–	Sell	-477	Closed	-$44.8K	–	468
2023 Q2	$44.8K	Buy	+477	New	+$37.2K	0.02%	179
2022 Q4	–	Sell	-377	Closed	-$12K	–	655
2022 Q3	$12K	Sell	377 -224	-37%	-$9.23K	﹤0.01%	226
2022 Q2	$24K	Sell	601 -59	-9%	-$3.15K	0.01%	183
2022 Q1	$46K	Buy	+660	New	+$48.2K	0.01%	58

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Elequin Capital's EXAS Position: Q1 2026 in Review

Elequin Capital sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 539 shares — an estimated $54.7K sold.

Elequin Capital first reported a position in EXAS in Q1 2022 and held it in 8 quarters. The position peaked at $54.7K in Q4 2025. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

Elequin Capital reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
Elequin Capital sold 539 Exact Sciences shares in Q1 2026, an estimated $54.7K.
Elequin Capital first reported a position in Exact Sciences in Q1 2022 and held it in 8 quarters.
Elequin Capital's Exact Sciences position peaked at $54.7K in Q4 2025.
6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Elequin Capital's 13F filing for Q1 2026, filed 11 May 2026.